These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 4539046

  • 21. [Treatment of rheumatic diseases with Sigma-Elmedal under spa-conditions].
    Engel P.
    Fortschr Med; 1974 Feb 21; 92(6):254-6. PubMed ID: 4544747
    [No Abstract] [Full Text] [Related]

  • 22. [Early clinical experiments with a new synthetic anti-inflammatory agent].
    Annoni G.
    Clin Ter; 1969 Jan 15; 48(1):9-51. PubMed ID: 5311536
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Value of clofezone in the treatment of rheumatic diseases].
    Stroescu I, Stoicescu M, Dragomir M, Burtea A, Pintea G, Stoia I.
    Schweiz Rundsch Med Prax; 1971 Feb 16; 60(7):217-20. PubMed ID: 5555631
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Treatment of degenerative and inflammatory joint diseases with or without a new synthetic substance (parsalmide). Controlled clinical trial].
    Napoli A, Alderuccio B, Nannetti A.
    Clin Ter; 1977 Dec 15; 83(5):541-7. PubMed ID: 343972
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Percluson (Clophezon)--clinical drug evaluation].
    Wysocka K, Szwed L.
    Pol Tyg Lek; 1973 Nov 26; 28(48):1902-3. PubMed ID: 4543746
    [No Abstract] [Full Text] [Related]

  • 32. [New medicamentous treatment of arthrosis and radiculalgic syndromes].
    Giard P.
    J Sci Med Lille; 1971 Nov 26; 89(11):441-5. PubMed ID: 5316266
    [No Abstract] [Full Text] [Related]

  • 33. [Meprotixol (N 7020). Studied in rheumatic diseases in a double blind multicenter investigation in general practice].
    Kogstad O, Apall-Olsen P, Fjerdingstad S, Garfelt R, Helgesen RO, Joheim I, Klaastad R, Rosenberg I, Selvåg J, Toreid K, Tonnessen JS.
    Tidsskr Nor Laegeforen; 1974 Feb 10; 94(4):209-12. PubMed ID: 4595468
    [No Abstract] [Full Text] [Related]

  • 34. [Treatment of rheumatic diseases with Prednirheumin-combi].
    Kovács L.
    Ther Ggw; 1972 Dec 10; 111(12):1788-90 passim. PubMed ID: 4569032
    [No Abstract] [Full Text] [Related]

  • 35. [On the treatment of chronic rheumatic diseases with orthoxyquinoline sulfonate of dimethyl-amino-phenazone].
    Alberto S, Brusasco L, Colongo PG.
    Minerva Med; 1967 Mar 03; 58(18 Suppl):762-6. PubMed ID: 5297789
    [No Abstract] [Full Text] [Related]

  • 36. [On the treatment of rheumatic conditions in metabolic diseases using Dexamed-Butazone].
    André W.
    Med Welt; 1969 Jul 19; 29():1624-7. PubMed ID: 5306468
    [No Abstract] [Full Text] [Related]

  • 37. [Clinical experience with an indomethacin-phenylbutazone combination in various rheumatic diseases].
    Hernández Peńa M.
    Rev Esp Reum Enferm Osteoartic; 1973 Jul 19; 16(2):111-31. PubMed ID: 4541698
    [No Abstract] [Full Text] [Related]

  • 38. [Therapeutic study of an anti-inflammatory agent, Clofezone].
    David-Chaussé J, David-Chaussé F, Lagoarde J, Picot C.
    J Med Bord; 1967 Oct 19; 144(10):1529-35. PubMed ID: 5304355
    [No Abstract] [Full Text] [Related]

  • 39. [On clinical evaluation of the effect of azapropazon, a new anti-inflammatory agent, in diseases of the rheumatic group].
    Beckschäfer W.
    Arzneimittelforschung; 1969 Jan 19; 19(1):52-3. PubMed ID: 4182977
    [No Abstract] [Full Text] [Related]

  • 40. Treatment of rheumatic disease.
    Cooper P.
    Midwife Health Visit Community Nurse; 1975 May 19; 11(5):155. PubMed ID: 1079071
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.